These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20128612)

  • 1. Targeted dendrimeric anticancer prodrug: a methotrexate-folic acid-poly(amidoamine) conjugate and a novel, rapid, "one pot" synthetic approach.
    Zhang Y; Thomas TP; Desai A; Zong H; Leroueil PR; Majoros IJ; Baker JR
    Bioconjug Chem; 2010 Mar; 21(3):489-95. PubMed ID: 20128612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bifunctional PAMAM dendrimer conjugates of folic acid and methotrexate with defined ratio.
    Zong H; Thomas TP; Lee KH; Desai AM; Li MH; Kotlyar A; Zhang Y; Leroueil PR; Gam JJ; Banaszak Holl MM; Baker JR
    Biomacromolecules; 2012 Apr; 13(4):982-91. PubMed ID: 22360561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting and inhibition of cell growth by an engineered dendritic nanodevice.
    Thomas TP; Majoros IJ; Kotlyar A; Kukowska-Latallo JF; Bielinska A; Myc A; Baker JR
    J Med Chem; 2005 Jun; 48(11):3729-35. PubMed ID: 15916424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical antitumor efficacy evaluation of dendrimer-based methotrexate conjugates.
    Myc A; Douce TB; Ahuja N; Kotlyar A; Kukowska-Latallo J; Thomas TP; Baker JR
    Anticancer Drugs; 2008 Feb; 19(2):143-9. PubMed ID: 18176110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design considerations for PAMAM dendrimer therapeutics.
    Goonewardena SN; Kratz JD; Zong H; Desai AM; Tang S; Emery S; Baker JR; Huang B
    Bioorg Med Chem Lett; 2013 May; 23(10):2872-5. PubMed ID: 23583511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendrimeric anticancer prodrugs for targeted delivery of ursolic acid to folate receptor-expressing cancer cells: synthesis and biological evaluation.
    Gao Y; Li Z; Xie X; Wang C; You J; Mo F; Jin B; Chen J; Shao J; Chen H; Jia L
    Eur J Pharm Sci; 2015 Apr; 70():55-63. PubMed ID: 25638419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality.
    Majoros IJ; Myc A; Thomas T; Mehta CB; Baker JR
    Biomacromolecules; 2006 Feb; 7(2):572-9. PubMed ID: 16471932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folate Receptor-Targeted Dendrimer-Methotrexate Conjugate for Inflammatory Arthritis.
    Qi R; Majoros I; Misra AC; Koch AE; Campbell P; Marotte H; Bergin IL; Cao Z; Goonewardena S; Morry J; Zhang S; Beer M; Makidon P; Kotlyar A; Thomas TP; Baker JR
    J Biomed Nanotechnol; 2015 Aug; 11(8):1431-41. PubMed ID: 26295143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyvalent dendrimer-methotrexate as a folate receptor-targeted cancer therapeutic.
    Thomas TP; Huang B; Choi SK; Silpe JE; Kotlyar A; Desai AM; Zong H; Gam J; Joice M; Baker JR
    Mol Pharm; 2012 Sep; 9(9):2669-2676. PubMed ID: 22827500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyvalent saccharide-functionalized generation 3 poly(amidoamine) dendrimer-methotrexate conjugate as a potential anticancer agent.
    Zhang Y; Thomas TP; Lee KH; Li M; Zong H; Desai AM; Kotlyar A; Huang B; Holl MM; Baker JR
    Bioorg Med Chem; 2011 Apr; 19(8):2557-64. PubMed ID: 21459000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy.
    Majoros IJ; Thomas TP; Mehta CB; Baker JR
    J Med Chem; 2005 Sep; 48(19):5892-9. PubMed ID: 16161993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the internalization of targeted dendrimers and dendrimer-entrapped gold nanoparticles into cancer cells.
    Shi X; Wang SH; Lee I; Shen M; Baker JR
    Biopolymers; 2009 Nov; 91(11):936-42. PubMed ID: 19603491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex.
    Patri AK; Kukowska-Latallo JF; Baker JR
    Adv Drug Deliv Rev; 2005 Dec; 57(15):2203-14. PubMed ID: 16290254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular heterogeneity analysis of poly(amidoamine) dendrimer-based mono- and multifunctional nanodevices by capillary electrophoresis.
    Shi X; Majoros IJ; Patri AK; Bi X; Islam MT; Desai A; Ganser TR; Baker JR
    Analyst; 2006 Mar; 131(3):374-81. PubMed ID: 16496045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioanalytical method development for a generation 5 polyamidoamine folic acid methotrexate conjugated nanoparticle.
    van Haandel L; Stobaugh JF
    Anal Bioanal Chem; 2010 Jul; 397(5):1841-52. PubMed ID: 20431871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the efficacy of a dendrimer-based nanotherapeutic in heterogeneous xenograft tumors in vivo.
    Myc A; Kukowska-Latallo J; Cao P; Swanson B; Battista J; Dunham T; Baker JR
    Anticancer Drugs; 2010 Feb; 21(2):186-92. PubMed ID: 20010426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and characterization of G5 PAMAM dendrimer containing daunorubicin for targeting cancer cells.
    Yue Y; Eun JS; Lee MK; Seo SY
    Arch Pharm Res; 2012 Feb; 35(2):343-9. PubMed ID: 22370789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifunctional dendrimer/combretastatin A4 inclusion complexes enable in vitro targeted cancer therapy.
    Zhang M; Guo R; Wang Y; Cao X; Shen M; Shi X
    Int J Nanomedicine; 2011; 6():2337-49. PubMed ID: 22072871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of folic acid functionalized bioactive glass for targeted delivery and sustained release of methotrexate.
    Chen J; Chen X; Yang Z; Tan X; Wang J; Chen Y
    J Biomed Mater Res A; 2019 Feb; 107(2):319-329. PubMed ID: 30450695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid-modified methotrexate-conjugated gold nanoparticles as nano-sized trojans for drug delivery to folate receptor-positive cancer cells.
    Yücel O; Şengelen A; Emik S; Önay-Uçar E; Arda N; Gürdağ G
    Nanotechnology; 2020 Aug; 31(35):355101. PubMed ID: 32413875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.